Report: H-E-B expands ‘Mi Tiendo’ Latin format to Austin market
AUSTIN, Texas — H-E-B is bringing its "Mi Tiendo" Latin format to the Austin market, according to a report published last week by American-Statesman.
According to the report, H-E-B expanded one of its Austin locations by 6,000 sq. ft. of selling space to incorporate Latin-centric grocery fare, including a masa factory that grinds corn daily, a tortillas-producing machine and a butcher and deli featuring Latin cuisine.
The concept has been available in two locations in the Houston market, the report added.
RediClinic kicks off new year with Weigh Forward introductory package
HOUSTON — It’s the new year, and for many people that means setting a resolution to drop those extra pounds. In an effort to help consumers meet that goal, RediClinic is offering an introductory price for its Weigh Forward weight-loss program.
The exclusive limited-time offer gives patients access to one visit with a specially-trained clinician at RediClinic. The introductory package, priced at $99, also includes:
Three weeks of meal plans and a selection of recipes;
Body composition analysis;
Lipo B injection;
Sample supplement kit.
Weigh Forward, which was developed in partnership with weight-loss expert David L. Katz, M.D., kicked off May 2011 at all 29 RediClinic locations in H-E-B stores in Houston, Austin and San Antonio.
Credit Suisse: December drug channel comps will be lackluster
NEW YORK — Retailers will report weak December front-end sales growth across the drug channel as continued inflation likely was offset by the slow start to the flu season and disappointing overall traffic and volume growth, Credit Suisse research analyst Ed Kelly suggested in a note published Tuesday.
"While drug stores have been fairly successful passing through product cost inflation at the shelf, our Nielsen Trend Tracker shows that volumes have decelerated in recent months given the weak consumer and normal price elasticity," he wrote.
In addition to the economy, year-over-year prescription growth was down 70 basis points for the four weeks ended Dec. 16, Kelly noted, citing IMS Health data.
Kelly projected Walgreens comparable sales will be flat for December (the chain’s monthly sales will be released Jan. 5) on account of difficult year-ago comparisons across the front end and an acceleration of lost Express Script prescriptions. Kelly expects the Express Script impact to accelerate from November — to a 200 basis point impact from the 110 basis point impact reported in November.
Kelly projected Rite Aid total same-store sales will be up between 1% and 2%, with a 0.5% lift across front-end comparable sales and a 2% lift across pharmacy sales — a projection that incorporates a negative 200 basis-point impact from new generics, such as Lipitor. Rite Aid reports December sales Jan. 4.